Instead of gathering at someone’s home this Thanksgiving, make plans for a destination Thanksgiving getaway that the entire family will enjoy.
Thomas Belczak officiated at a funeral Mass Thursday before being removed as pastor.
Bosch says it will nearly double the facility’s size and bring up to 200 new jobs in the next three years.
Esperion Therapeutics Inc., (Nasdaq: ESPR), the pharmaceutical company developing promising new cholesterol therapies, reported a big loss for 2013 — but continued promising clincal trial results.
Rofin-Sinar Technologies Inc., a Plymouth maker of industrial lasers, announced that it had an agreement to acquire the assets of Portland, Ore.-based FiLaser USA LLC.
The weight of this season’s snow may be to blame for a roof collapse in Plymouth.
Both Midland-based Dow Corning Corp. and Rofin-Sinar Technologies Inc. of Plymouth reported earnings this week for the quarter ended Dec. 31.
The cancer drug developer ProNAi Therapeutics Inc. Monday announced the closing of a Series C preferred financing round of more than $12 million with existing and new investors.
Esperion Therapeutics Inc. (Nasdaq: ESPR) says its shares have been added to the Nasdaq Biotechnology Index effetive Dec. 23.
Plymouth-based Humanetics Innovative Solutions Inc. and affiliated companies Wednesday announced their acquisition by Golden Gate Capital, a San Francisco private equity firm.